A unified picture describing how sphingolipid metabolism as a whole is reconfigured in cancer is yet to emerge, however it is now well established that many cancers are characterised by up-regulation of SPHK1, which catalyses the synthesis of the pro-survival, pro-angiogenic lipid signalling molecule S1P [4,9]. Here, SPHK1 is linked to cancer.